Therapeutics Development

Browse the following groundbreaking articles specially selected by our Editors.

Enjoy free access until December 10, 2018. Open access articles are freely available online on a permanent basis.

Antibodies pose a double threat to HIV
From Nature
L_nature_mini_logo
Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys
From Nature
L_nature_mini_logo
C21 steroid derivatives from the Dai herbal medicine Dai-Bai-Jie, the dried roots of Marsdenia tenacissima, and their screening for anti-HIV activity
From Journal of Natural Medicines
L_springer_mini_logo
Combination therapy with anti-HIV-1 antibodies maintains viral suppression
From Nature
L_nature_mini_logo
Crystal structures of trimeric HIV envelope with entry inhibitors BMS-378806 and BMS-626529
From Nature Chemical Biology​​​​​​​
L_natureresearch_mini_logo
Differential Effects of Strategies to Improve the Transduction Efficiency of Lentiviral Vector that Conveys an Anti-HIV Protein, Nullbasic, in Human T Cells
From Virologica Sinica​​​​​​​
L_springer_mini_logo
Effects of voluntary exercise on antiretroviral therapy-induced neuropathic pain in mice
From The Journal of Physiological Sciences​​​​​​​
L_springer_mini_logo
Exploration of the effect of sequence variations located inside the binding pocket of HIV-1 and HIV-2 proteases
From Scientific Reports​​​​​​​
L_natureresearch_mini_logo
Genome editing of the HIV co-receptors CCR5 and CXCR4 by CRISPR-Cas9 protects CD4+ T cells from HIV-1 infection
From Cell & Bioscience ​​​​​​​
L_brandstrip_bmc
HIV and the Macrophage: From Cell Reservoirs to Drug Delivery to Viral Eradication
From Journal of Neuroimmune Pharmacology​​​​​​​
L_springer_mini_logo
HIV Persistence on Antiretroviral Therapy and Barriers to a Cure
From the book HIV Vaccines and Cure
L_springer_mini_logo
Improved production of 1-deoxynojirymicin in Escherichia coli through metabolic engineering
From World Journal of Microbiology and Biotechnology​​​​​​​
L_springer_mini_logo
Molecular Control of HIV and SIV Latency
From the book HIV-1 Latency​​​​​​​
L_springer_mini_logo
Ultra-long-acting removable drug delivery system for HIV treatment and prevention
From Nature Communications​​​​​​​
L_natureresearch_mini_logo​​​​​​​​​​​​​​